Maintain BUY with a TP of Rs745, 14x Dec-19E. We attended Persistents (PSYS) Investor Meet, as the company showcased its digital prowess with multiple use-cases/demos and a peek into its hackathons. We maintain our faith on PSYS and expect growth ahead, based on (1) New partnerships (USAA, Partners HealthCare), (2) Market expansion (Parx to support ramp-up in Europe), (3) New large logo wins in Digital and its scalability, and (4) Focus on sales re-alignment to improve cross-sell. We believe that the structural transformation is underway with increasing share of IPs and digital in the overall mix (29% of rev).